FibroGen Inc Capital Reinvestment Ratio

Latest as of June 2025: 0.00x

FibroGen Inc capital reinvestment ratio. FibroGen Inc (FGEN) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow ($12.68 Million) in capital expenditures ($13.00K). Check how aggressively does FibroGen Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$12.68 Million
USD

Capital Expenditures

$13.00K
USD

Data as of

Jun 2025
Most recent filing

Capital Reinvestment Ratio of FibroGen Inc (2013–2020)

Capital reinvestment ratio of FibroGen Inc from 2013 to 2020. This chart tracks FibroGen Inc's Capital Reinvestment Ratio across 4 annual periods. Also explore FibroGen Inc equity growth rate to track the company's year-over-year net asset growth rate.

FibroGen Inc Capital Reinvestment Ratio by Year (2013–2020)

FibroGen Inc capital reinvestment ratio by year from 2013 to 2020. For the full cash flow conversion analysis, see FibroGen Inc (FGEN) cash conversion ratio.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2020 0.05x $81.60 Million $3.99 Million ▼ -72.2%
2016 0.18x $7.11 Million $1.25 Million ▼ -51.4%
2014 0.36x $22.41 Million $8.12 Million ▲ +37.9%
2013 0.26x $25.92 Million $6.81 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow